CELC
CelcuityDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
Current thesis
Bullish view rests on the June 2 VIKTORIA-1 mutant-cohort result: the gedatolisib triplet beat the comparator on PFS, safety was described as manageable, and management says the FDA submission and commercial launch path remain on track [#8-K-2026-06-02] [#SEC-8K-2026-03-25]. The VIKTORIA-2 expansion and subcutaneous formulation work add longer-dated upside if the launch goes well.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +20.9.
What can break
Cash burn and expense ramp: the Q1 2026 update showed a $52.8M net loss and $55.1M in operating cash use, with R&D and SG&A both elevated as launch spending rises [#PR-EARNINGS-2026-05-15].
Momentum
11
Value
41
Sentiment
73
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $114.00 · Bull $145.00 · Bear $68.00
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-22 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $163.45
Why
Momentum11 · Δ7d +1.2
Value41 · Δ7d -0.0
Sentiment73 · Δ7d +20.9
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
11
26% active weight
Current posture
7d trendSoftening
Δ7d
+1.2
Δ21d
+12.2
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.1
Sentiment
73
34% active weight
Current posture
7d trendImproving
Δ7d
+20.9
Δ21d
+13.7
Why this grade
Composite grade D. Momentum 11.3 / Value 41.1 / Sentiment 73.1
Fundamentals (TTM)As of 2026-07-22
Fundamentals (TTM)
As of 2026-07-22
Market Cap
$4.4B
Beta
0.37
Shares Out
48.77M
P/E (TTM) · Derived
-23.8
P/S (TTM)
-
P/FCF (TTM) · Derived
-25.88
Rev YoY
-
EPS YoY
+12.9%
Gross Margin
-
Op Margin
-
Net Debt
-$119.59M
Current Ratio
12.31
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology